Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysisAlberto Martini, Andrea Necchi, Daniele Raggi et al.|Cancer Treatment Reviews|2022Cited by 34
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysisGiuseppe Fallara, Alberto Martini, Daniele Robesti et al.|Cancer Treatment Reviews|2022Cited by 33
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping reviewTiago Costa de Pádua, Andrea Necchi, Marco Moschini et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 29
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial CarcinomaAlberto Martini, Marco Moschini, Chiara Lonati et al.|European Urology Oncology|2022Cited by 26
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysisGiuseppe Fallara, Alberto Martini, Federico Belladelli et al.|Critical Reviews in Oncology/Hematology|2022Cited by 13